Argenx Se (ARGX) Cash & Equivalents (2015 - 2026)

Argenx Se (ARGX) posted quarterly Cash & Equivalents of $3.6 billion for Q2 2026, up 71.81% year-on-year from $2.1 billion in Q2 2025, and up 2.66% on a QoQ basis from $3.5 billion in Q4 2025.

Argenx Se (ARGX) Cash & Equivalents (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Cash & Equivalents for 12 consecutive years, with $3.6 billion the latest figure, recorded in Q2 2026.

  • Quarterly Cash & Equivalents rose 71.81% year-over-year to $3.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.6 billion (up 71.81% YoY) and the FY2025 annual result came in at $3.5 billion, up 132.73% from the prior year.
  • Cash & Equivalents grew to $3.6 billion in Q2 2026 per ARGX's latest filing, from $3.5 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for ARGX reached as high as $3.6 billion in Q2 2026 and fell as low as $800.7 million in Q4 2022.
  • A 5-year average of $1.9 billion and a median of $1.5 billion in 2024 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents sank 40.0% — and 2023, when it surged 155.87%.
  • Year by year, Cash & Equivalents stood at $800.7 million in 2022, then jumped by 155.87% to $2.0 billion in 2023, then retreated by 26.79% to $1.5 billion in 2024, then soared by 132.73% to $3.5 billion in 2025, then increased by 2.66% to $3.6 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $3.6 billion, $3.5 billion, and $2.1 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 1.71 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.58 Bn
Dec 31, 2025 3.49 Bn
Jun 30, 2025 2.09 Bn
Dec 31, 2024 1.50 Bn
Jun 30, 2024 1.44 Bn
Dec 31, 2023 2.05 Bn
Jun 30, 2023 1.11 Bn
Dec 31, 2022 800.74 Mn
Jun 30, 2022 1.37 Bn
Dec 31, 2021 1.33 Bn
Jun 30, 2021 1.58 Bn
Dec 31, 2020 1.13 Bn
Jun 30, 2020 1.35 Bn
Dec 31, 2019 376.98 Mn
Jun 30, 2019 190.94 Mn
Dec 31, 2018 319.81 Mn
Jun 30, 2018 203.30 Mn
Dec 31, 2017 275.46 Mn
Jun 30, 2017 109.01 Mn
Dec 31, 2016 129.74 Mn